KORRO BIO INC

CEO Aiyar Ram sells vested shares, fueling Korro Bio’s RNA therapy pipeline and revealing recent equity activity amid market volatility.

Korro Bio Inc, a biopharmaceutical company focused on RNA therapies, faces significant financial challenges and volatility, raising questions about its stability and future prospects.